[Treatment with continuous transpulmonary pressure and with intermittent positive pressure respiration, through nasal cannulas, of a newborn girl with the narcotic withdrawal syndrome and apnea crisis].
D000328:Adult; D001049:Apnea / Q000628:therapy*; D005260:Female; D003932:Heroin / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced*; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects*; D009020:Morphine / Q000009:adverse effects*; D010423:Pentazocine / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications; D012121:Respiration, Artificial; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000628:therapy*; D019966:Substance-Related Disorders
D003932:Heroin; D009020:Morphine; D008238:Lysergic Acid Diethylamide; D010423:Pentazocine
Trattamento con pressione transpolmonare continua (PTC) e con pressione positiva intermittente (PPI) tramite cannule nasali di una neonata con sindrome di astinenza da stupefacenti e crisi di apnea.